Reuters: Novartis-higher Glivec doses effective in leukaemia

[NaDiNe]

Novartis-higher Glivec doses effective in leukaemia
      

ZURICH (Reuters) - Leukaemia patients receiving a higher initial dose of Novartis AG's Glivec showed better early responses than those taking smaller quantities, the Swiss drugmaker said on Friday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login